S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Laser breakthrough could send stock soaring 2,467% (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
NASDAQ:CRIS

Curis (CRIS) News Today

$6.59
-1.01 (-13.29%)
(As of 09/29/2023 ET)
Compare
Today's Range
$6.00
$7.43
50-Day Range
$7.60
$131.80
52-Week Range
$6.00
$20.00
Volume
202,048 shs
Average Volume
15,414 shs
Market Capitalization
$38.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$90.00
SourceHeadline
MarketBeat logoCuris (NASDAQ:CRIS) Hits New 52-Week Low at $6.00
americanbankingnews.com - October 1 at 1:44 AM
markets.businessinsider.com logoBuy Rating for Curis (CRIS) Amidst Reverse Stock Split and Revised Launch Estimates for Key Product, Emavusertib
markets.businessinsider.com - September 29 at 3:42 PM
MarketBeat logoHC Wainwright Weighs in on Curis, Inc.'s FY2023 Earnings (NASDAQ:CRIS)
americanbankingnews.com - September 28 at 1:22 AM
thestreet.com logoCuris Reaches New 52-Week High (CRIS)
thestreet.com - September 26 at 9:08 PM
MarketBeat logoCuris (NASDAQ:CRIS) Given "Buy" Rating at HC Wainwright
americanbankingnews.com - September 26 at 4:12 AM
MarketBeat logoCuris (NASDAQ:CRIS) Receives New Coverage from Analysts at StockNews.com
americanbankingnews.com - September 26 at 3:32 AM
nasdaq.com logoHC Wainwright & Co. Reiterates Curis (CRIS) Buy Recommendation
nasdaq.com - September 25 at 4:38 PM
markets.businessinsider.com logoAnalyst Ratings for Curis
markets.businessinsider.com - September 25 at 11:38 AM
markets.businessinsider.com logoPromising Developments in Curis’s AML and MDS Treatment Research Bolster Buy Rating: A Detailed Look at Emavusertib’s Potential
markets.businessinsider.com - September 25 at 6:38 AM
finance.yahoo.com logoCuris Announces Date for the 2nd Symposium on IRAK4 in Cancer
finance.yahoo.com - September 12 at 6:48 PM
ftw.usatoday.com logoNFL fans roasted Cris Collinsworth for trying to argue that Patrick Mahomes is underrated
ftw.usatoday.com - September 10 at 6:05 PM
markets.businessinsider.com logoExpert Ratings for Curis
markets.businessinsider.com - September 7 at 3:30 PM
technews.tmcnet.com logoOne of America's Fastest Growing Healthcare Groups, Curis Functional Health, Partners With Adonis to Centralize Revenue Operations
technews.tmcnet.com - August 17 at 5:58 PM
finance.yahoo.com logoCuris, Inc. (NASDAQ:CRIS) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 5 at 8:39 AM
washingtonpost.com logoCuris: Q2 Earnings Snapshot
washingtonpost.com - August 3 at 7:32 PM
msn.com logoCuris (CRIS) Reports Q2 Loss, Misses Revenue Estimates
msn.com - August 3 at 7:32 PM
msn.com logoCuris (CRIS) Price Target Decreased by 11.11% to 6.12
msn.com - August 3 at 7:32 PM
finance.yahoo.com logoCuris Provides Second Quarter 2023 Business Update
finance.yahoo.com - August 3 at 7:32 PM
finance.yahoo.com logoCuris to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023
finance.yahoo.com - July 28 at 10:36 AM
msn.com logoCantor Fitzgerald Reiterates Curis (CRIS) Overweight Recommendation
msn.com - July 11 at 3:27 PM
markets.businessinsider.com logoAnalyst Holds Steady On Curis As FDA Removes Partial Clinical Hold On Leukemia Study
markets.businessinsider.com - July 7 at 4:44 PM
msn.com logoHC Wainwright & Co. Maintains Curis (CRIS) Buy Recommendation
msn.com - July 7 at 11:43 AM
seekingalpha.com logoCuris launches ~$15.1M registered direct offering
seekingalpha.com - July 6 at 12:28 PM
markets.businessinsider.com logoCuris: FDA Removes Partial Clinical Hold On TakeAim Leukemia Study
markets.businessinsider.com - July 6 at 12:28 PM
finance.yahoo.com logoCuris Announces $15.1 Million Registered Direct Offering
finance.yahoo.com - July 6 at 12:28 PM
msn.com logoCuris says FDA lifted partial clinical hold on leukemia trial
msn.com - July 6 at 12:28 PM
msn.com logoWhy Curis (CRIS) Shares Are Nosediving Thursday
msn.com - July 6 at 12:28 PM
prnewswire.com logoFDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID
prnewswire.com - July 6 at 8:11 AM
finance.yahoo.com logoInvestors in Curis (NASDAQ:CRIS) have unfortunately lost 50% over the last five years
finance.yahoo.com - June 30 at 8:08 AM
finance.yahoo.com logoIs Curis, Inc. (NASDAQ:CRIS) Trading At A 47% Discount?
finance.yahoo.com - June 6 at 8:57 AM
finance.yahoo.com logoIs Curis (NASDAQ:CRIS) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - May 15 at 3:13 PM
markets.businessinsider.com logoCuris (CRIS) Gets a Buy from JonesTrading
markets.businessinsider.com - May 9 at 12:39 PM
finance.yahoo.com logoCuris Provides First Quarter 2023 Business Update
finance.yahoo.com - May 4 at 7:26 PM
finance.yahoo.com logoCuris to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023
finance.yahoo.com - April 27 at 8:15 PM
finance.yahoo.com logoCuris, Inc. (NASDAQ:CRIS) Shares Fly 75% But Investors Aren't Buying For Growth
finance.yahoo.com - April 17 at 8:43 AM
seekingalpha.com logoCuris to grant stock options for 135.45K shares to new hire
seekingalpha.com - April 8 at 1:08 PM
nasdaq.com logoCuris, Inc. Common Stock (CRIS)
nasdaq.com - April 7 at 5:37 AM
finance.yahoo.com logoCuris to Present at Upcoming Healthcare Conferences in April
finance.yahoo.com - April 3 at 10:27 AM
benzinga.com logoCuris's Return On Capital Employed Overview
benzinga.com - March 17 at 7:46 AM
finance.yahoo.com logoCuris, Inc. (NASDAQ:CRIS) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 14 at 5:10 PM
finance.yahoo.com logoQ4 2022 Curis Inc Earnings Call
finance.yahoo.com - March 13 at 11:43 PM
finance.yahoo.com logoCuris (CRIS) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 13 at 6:42 PM
finance.yahoo.com logoCuris Provides Fourth Quarter 2022 Business Update
finance.yahoo.com - March 13 at 8:25 AM
markets.businessinsider.com logoWhat Wall Street expects from Curis's earnings
markets.businessinsider.com - March 13 at 3:24 AM
finance.yahoo.com logoCuris Reschedules Fourth Quarter 2022 Business Update and Conference Call
finance.yahoo.com - March 9 at 12:12 AM
finance.yahoo.com logoCuris to Release Fourth Quarter 2022 Financial Results and Hold Conference Call on March 9, 2023
finance.yahoo.com - March 2 at 7:47 PM
finance.yahoo.com logoInvestors in Curis (NASDAQ:CRIS) have unfortunately lost 80% over the last five years
finance.yahoo.com - January 20 at 1:17 PM
finance.yahoo.com logoCuris Announces Additional Encouraging Clinical Data from TakeAim Leukemia Study of emavusertib (CA-4948) in Monotherapy R/R AML and hrMDS
finance.yahoo.com - December 12 at 6:06 PM
marketbeat.com logo
marketbeat.com - December 12 at 10:05 AM
prnewswire.com logoCuris to Host Webcast to Discuss Updated Emavusertib Clinical Data in Leukemia
prnewswire.com - December 5 at 11:28 PM
Get Curis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter.



CRIS Media Mentions By Week

CRIS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRIS
News Sentiment

-0.20

0.69

Average
Medical
News Sentiment

CRIS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRIS Articles
This Week

16

1

CRIS Articles
Average Week

Get Curis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CRIS) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -